Are visceral fat, type 2 diabetes, insulin resistance, and low testosterone bidirectionally linked?

The relationship between testosterone levels and metabolic health in men is highly integrated and bidirectional, forming a complex metabolic loop.

Clinical evidence of metabolic dysfunction

• Prevalence of hypogonadism: Up to 40% to 50% of men with type 2 diabetes and central obesity exhibit clinical or biochemical hypogonadism.
• Impact of testosterone restoration: In hypogonadal men with metabolic syndrome or type 2 diabetes, restoring physiological testosterone levels reduces insulin resistance (assessed via HOMA-IR or hyperinsulinemic-euglycemic clamp) by approximately 15% to 32%, while concurrently reducing visceral adiposity, waist circumference, and HbA1c.

Mechanistic pathways of the metabolic loop

• HPT axis suppression: Visceral adipose tissue overexpresses the aromatase enzyme (CYP19A1), which accelerates the conversion of testosterone to estradiol. This estrogenic state, combined with visceral fat-derived inflammatory cytokines and leptin resistance, suppresses the hypothalamic-pituitary-testicular (HPT) axis.
• Insulin-mediated androgen reduction: Hyperinsulinemia resulting from insulin resistance directly suppresses the hepatic synthesis of sex hormone-binding globulin (SHBG), lowering measurable total testosterone. Additionally, insulin resistance directly impairs testicular Leydig cell function.
• Adipose receptor signaling: Visceral fat contains a high density of androgen receptors. Testosterone deficiency impairs this signaling, leading to increased lipoprotein lipase (LPL) activity and decreased hormone-sensitive lipase (HSL/LIPE)-mediated lipolysis, which drives visceral adipocyte hypertrophy and ectopic lipid deposition.

Bottom line

• A self-perpetuating bidirectional loop links low testosterone with metabolic dysfunction. Visceral adiposity and insulin resistance suppress testosterone production through inflammatory and enzymatic pathways, while testosterone deficiency actively promotes visceral fat accumulation and worsens systemic insulin resistance.